Evaluation of the efficacy of a combination of dapagliflozin and lobeglitazone on glucose concentrations and body fat in patients with type 2 diabetes: Location-F study

Diabetes Obes Metab. 2024 Mar;26(3):1114-1119. doi: 10.1111/dom.15388. Epub 2023 Dec 11.

¹ Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
² Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
³ Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
⁴ Touchstone Diabetes Center, The University of Texas Health Science Center at Houston Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, Houston, Texas, USA.

No abstract available

Publication types